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Percoll-purified Treponema pallidum was evaluated as a fluorescent treponemal antibody-absorbed antigen.
Borderline and false-positive reactions were essentially eliminated, resulting in sensitivity and specificity of 100
and 95.5%, respectively. The lack of background debris improved the ease and speed of reading the test.
Since the introduction of the fluorescent treponemal anti-
body (FTA) test for the serodiagnosis of syphilis (2), the
preparation of Treponema pallidum antigen from infected
rabbit testicular tissue has not substantially changed. This is
despite the development of the hemagglutination (15, 17, 18,
22) and enzyme immunoassay (10, 14, 20) tests and modifi-
cations to the FTA test (7, 9, 11). The laclk of change has
been due, in part, to the difficulties associated with obtaining
large quantities of purified antigen that are free of contami-
nating host testicular tissue and retain morphological char-
acteristics and immunological reactivity.
Although Hunter et al. (7) standardized methodology for
preparing FTA-absorbed (ABS) antigen that was free of
rabbit globulin, sensitive techniques revealed that these T.
pallidum preparations were still contaminated with rabbit
testicular material (5). The development of the continuous
particle electrophoresis method for separation of T. pallidum
from testicular material (16) resulted in the availability of a
purified antigen for use in the FTA-ABS test. This continu-
ous particle electrophoresis antigen is no longer available,
and its preparation was technically difficult and expensive.
Furthermore, it was a low-yield procedure that resulted in
nonmotile, avirulent, and ultrastructurally damaged orga-
nisms (5, 16). The possibility exists, therefore, that antigenic
changes accompanying cell death were responsible for lot-
to-lot variability in FTA-ABS reactivity.
A new, rapid purification technique utilizing Percoll den-
sity gradient centrifugation has been described recently (5).
The organisms were shown to be ultrastructurally intact,
motile, virulent, and free of detectable soluble and insoluble
host testicular material. In this report we evaluate the use of
Percoll-purified T. pallidum as an FTA-ABS antigen. The
evidence presented suggests that the purity and quality of
the T. pallidum antigen preparation may have a direct effect
on the occurrence of equivocal and borderline reactions.
T. pallidum, Nichols strain, was maintained without
corticosteroids and harvested in FTA-ABS buffer (CSI, Inc.,
Whippany, N.J.) as previously described (5). To increase
bacterial yields for preparation of FTA-ABS antigen, rabbits
were given cortisone acetate from days 3 to 10 postinfection
(19). Soluble and insoluble host testicular tissue was re-
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moved from treponemal suspensions by low-speed differen-
tial centrifugation followed by density gradient centrifuga-
tion through Percoll (Pharmacia Fine Chemicals,
Piscataway, N.J.) as described elsewhere (5). Percoll was
removed from the purified treponemes by centrifugation at
100,000 x g for 1 h at 4°C (5), and the organisms were diluted
1:20 in lyophilization buffer (8) and maintained at 4°C for 10
days. Samples (0.5 ml) were lyophilized and stored at 4°C
until used (8). Purified T. pallidum antigen was reconstituted
in 0.5 ml of double-distilled water and adjusted to a working
concentration in FTA-ABS buffer. Before use, 10-well slides
(Carlson Scientific, Peotone, Ill.) were washed in 7x deter-
gent, rinsed in water, soaked in 95% ethanol, and allowed to
air dry. Ten microliters of the treponemal suspension was
placed in each well and allowed to air dry in a laminar-flow
hood. Antigen-coated slides were fixed in acetone for 10 min
and stored at -20°C (21). Antigen testing and titration-of the
fluorescein-conjugated anti-human globulih (BBL Microbiol-
ogy Systems, Cockeysville, Md.) were performed as de-
scribed (21). The reactive control serum and a total of 122
diagnostically and serologically well-characterized sera from
patients with syphilis and from patients with false-positive or
nonspecific fluoresence in the FTA-ABS test were gener-
ously provided by Sandra Larsen (Treponemal Research
Branch, Sexually Transmitted Disease Laboratory Program,
Center for Infectious Disease, Centers for Disease Control
[CDC]). The sera were selected for use on the basis of their
FTA-ABS reactivity. Approximately 20 sera each were
categorized as nonreactive, borderline, or 1-, 2-, 3-, and
4-plus reactive. The FTA-ABS test was performed as de-
scribed (21) and interpreted in a double-blind fashion by two
experienced readers. A positive test was considered to be a
result of 1 to 4+. A typical 3+ reaction is shown in Fig. 1.
Borderline reactions were noted but interpreted as negative
(1).
The FTA-ABS test with the purified antigen (FTA-P) and
the test performed at the CDC (FTA-CDC) detected 77 true
positives (Table 1). False-positives occurred with both tests,
but it is important to note that the false-positive results were
obtained with different sera. It also appears that the ability of
each test to correctly identify true negatives (normals and
individuals with diseases other than syphilis) was similar.
A significant difference in the number of borderline reac-
tions was observed, however. A total of 21 borderline
reactions occurred with the FTA-CDC test (Table 1). This
included 3 patients with treated latent syphilis, 1 with
congenital syphilis, 3 false-positives, and 14 normal individ-
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TABLE 1. FTA-ABS testing with Percoll-purified T. pallidum
No. of sera by testa:
Diagnostic FTA-CDC FTA-P
category
Reactiveb Borderline Nonreactive Reactiveb Borderline Nonreactive
Syphilisc 77 4 0 77 1 3
Other diseases 0 0 20 0 0 20
Normal 0 14 0 2 1 11
False-positive 4 3 0 0 0 7
a FTA-ABS testing performed at North Carolina Memorial Hospital with Percoll-purified T. pallidum (FTA-P) or by CDC with nonpurified antigen (FTA-CDC).
b Reactive, >1 + reaction.
c The diagnosis of syphilis was based on detailed historical, clinical, and serologic information provided to or obtained by the CDC. There were 21 patients with
untreated and treated early syphilis, 52 with untreated and treated latent disease, 7 with congenital syphilis, and 1 with late cardiovascular syphilis.
uals. When these sera were tested by the FTA-P 17 were
nonreactive, 2 remained borderline, and 2 became reactive.
Similarly, seven sera that were diagnostically categorized as
false-positives were nonreactive in the FTA-P. In contrast,
one 2+, three 1+, and three borderline reactions occurred
with the FTA-CDC. The sensitivity and specificity of the
FTA-P were 100 and 95.5%, and those of the FTA-CDC
were 98.7 and 90.9%, respectively.
All treponemal tests for syphilis utilize treponemal anti-
gens that are contaminated with rabbit testicular material.
The inability to obtain sufficient quantities of purified antigen
results from the fact that only limited in vitro multiplication
of the organism has been reported (3, 4, 12, 13). Further-
more, an efficient method for purification of T. pallidum from
host tissue has not been available. Recently, however, the
separation of soluble and insoluble host material from T.
pallidum suspensions by Percoll density gradient centrifuga-
tion was described (5). The resultant organisms were biolog-
ically, morphologically, and immunologically intact. Prelim-
inary evidence suggested that the use of Percoll-purified T.
pallidum as an FTA-ABS antigen reduced the number of
FIG. 1. Percoll-purified T. pallidum as an FTA-ABS antigen.
equivocal reactions and enhanced the ease and speed of
reading (P. A. Hanff, C. Fernandez, J. Waters, and J. D.
Folds, Progr. Abstr. 83rd Intersci. Conf. Antimicrob. Agents
Chemother., abstr. no. 669, 1983). This appeared to be due,
in part, to the purity of the antigen and the resultant lack of
background debris (5). Additionally, Percoll-purified antigen
remained firmly fixed to the slides throughout the procedure.
In contrast, some loss of the standard nonpurified antigen is
expected (6, 21).
In an attempt to demonstrate more accurately that Percoll-
purified T. pallidum could be effectively utilized as an
FTA-ABS antigen, we tested diagnostically and serologi-
cally well-characterized sera, using lyophilized purified an-
tigen. The sensitivity and specificity of the FTA-P and the
FTA-CDC were essentially similar: 100 and 95.5% versus
98.7 and 90.9%, respectively. There was a marked differ-
ence, however, in the number of borderline reactions ob-
served with the two tests. Of the 21 borderline results
measured by the CDC, 19 (95%) were nonreactive by the
FTA-P, and 2 became positive. The CDC currently recom-
mends that borderline reactions be interpreted as negative
(1). Thus, the differences observed between the FTA-P and
FTA-CDC may not be clinically significant.
In contrast, the fact that all patients classified as false-
positive were nonreactive with the FTA-P may have impor-
tant clinical and serologic implications. We have shown that
the quality and purity of the T. pallidum antigen have an
effect on borderline and false-positive FTA-ABS results.
Similar results have been obtained by comparing the reac-
tivity of a commercial FTA-ABS antigen with nonpurified
and Percoll-purified T. pallidum prepared from the same
suspension (G. Tringali, P. A. Hanff, G. Scuderi, and G.
Fragale, submitted for publication). If these results are
confirmed in larger prospective evaluations utilizing FTA-
ABS, hemagglutination, or enzyme-linked immunosorbent
assays, it is conceivable that many of the interpretive
problems encountered with the treponemal tests for syphilis
and the resultant diagnostic dilemmas will be resolved.
We thank Elizabeth Hunter for invaluable conversations and
guidance, Jennifer Waters for technical assistance, and Lydia
Moretti for excellent secretarial assistance.
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